Andrew Sinclair - 09 Aug 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Reporting relationship: Director
Issuer ticker: VRNA
Reported as of: 09 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Aug 2021, 16:42:40 UTC
Prior SEC filing: 09 Jun 2021
Next SEC filing: 13 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Claire Poll, Attorney-in-fact for Andrew Sinclair

Key filing fact

Andrew Sinclair filed Form 4 for Verona Pharma plc (VRNA) on 10 Aug 2021.

Key facts

This page summarizes Andrew Sinclair's Form 4 filing for Verona Pharma plc (VRNA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Aug 2021, 16:42.

Change

Previous filing in this sequence was filed on 09 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRNA transaction Derivative

Share Options (Right to Buy)

Award

Transaction value: $0
Shares: +64,000
Change %
Price: $0.000000
Shares after: 64,000
Date: 09 Aug 2021
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 64,000
Exercise price: $0.7750
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

Footnote F2

The option vests and becomes exercisable as to 25% on August 9, 2021, 25% on November 1, 2021, 25% on February 1, 2022 and 25% on May 1, 2022.